Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you look at my earlier posts I said that Liberty could make a big play with flower in the near term. This market (florida) is huge. It is about to explode. Huge majority of people want it legalized and like a hive of bees buzzing they are buzzing. It was a very smart play to focus on Florida. There is more than enough market here to grab in flower alone...If I am correct watch for the company advertising different flower strains more frequently. For every 10 patients count it as 12 because people are prescribed more than enough flower.
Item 9 Labs Corp. Reports Continued Revenue Growth in Third Quarter ResultsPress Release | 08/20/2019
PHOENIX, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, reported operating results on August 16, 2019 for the third quarter which ended June 30, 2019.
Item 9 Labs Corp. and its subsidiaries continued their revenue growth in the three month and nine month periods ending June 30, 2019. Operating efficiency increased dramatically as seen in the margins growth over the same periods compared to fiscal year 2018. The expansion of the Arizona facility, completed in March 2019, should prove to increase the efficiency and revenues beginning in Q4.
“Throughout this fiscal quarterly period ended June 30, 2019, we have exhibited exponential revenue growth and expansion of our business operations. We accomplished our construction initiatives for our core facilities in Nevada and Arizona, more than doubling our cultivation space allowing us to bring new and diverse product suites to market. In addition, we have solidified partnerships in North Dakota, keeping us on pace towards applying, and managing cultivation, processing, distribution, and dispensary operations in six to 10 U.S markets by the end of 2019,” said CEO Sara Gullickson.
“As a Company, we have achieved significant milestones on a national and local level, including filing our Form 10 Registration Statement, ranking as one of the fastest growing cannabis concentrate brands in Arizona, and receiving first place honors for the second consecutive at the ERRL Cup Awards for our Sativa flower strain. Moving forward, we intend to build upon this momentum and are grateful for our shareholders support,” Gullickson said
Chief Financial Officer Bobby Mikkelsen added, “Our Form 10 filing coupled with our solid financial results are evidence of our continued commitment to strategic growth as a fully reporting public company. In the final fiscal quarter, we remain focused on opportunities to enhance revenue growth, increase margins, and maximize shareholder value.”
Overview for the three months ending June 30, 2019, as compared to the three months ending June 30, 2018:
Revenue increased 251% to $1,542,067.
Operating margins increased to 55% from 14%.
Pre-tax earnings of Item 9 Labs operating entities totaled $491,553.
Net loss of $864,176.
Diluted loss per share of $.01.
Overview for the nine months ending June 30, 2019 as compared to the nine months ending June 30, 2018:
Revenue increased 284% to $3,627,951.
Operating margins increased to 53% from 27%.
Pre-tax earnings of Item 9 Labs operating entities totaled $987,962.
Net loss of $2,077,363.
Diluted loss per share of $.03.
Company Updates
Filed Form 10 Registration Statement with the US Securities and Exchange Commission.
Completed construction and received approval to operate on Arizona expansion , more than doubling cultivation space.
Strive Grand Forks North Dakota opened on May 22nd, 2019 through strategic partnership.
Construction broke ground on new corporate offices in downtown Phoenix.
Kyle Jennings, vice president of marketing and Josh Buckheister, creative director were added to the team and began employment March 1st. The official release for their hiring was announced on June 28th.
Accomplishments
Recorded largest sales month in Item 9 Labs history in April at $573,000.
Record “420” sales, released April 20th promotional box with first look at broad spectrum cartridge, prepackaged jarred flower, and marketing collateral.
º The week prior to April 20 sales hit $218,000.
Successfully activated “On the Grass Music Festival” title sponsorship.
º 15,000 attendees.
º Item 9 Labs branded stages, 40 x 60 lounge, and VIP area.
º 470% increase in social media and web impressions week prior and immediately following event with 170,000 impressions, up from an average of 30,000 impressions.
º 100 exclusive Item 9 Labs festival boxes leveraged in partner dispensaries.
Secured three-year category exclusive sponsorship with Marquee Theater in Tempe, Arizona:
º Average of 115 shows per year.
º Average attendance of 1,500 per show with an expected annual attendance of more than 170,000.
º Item 9 Labs interior branding.
º Item 9 Labs inclusion on web, print, radio, and social media.
For information visit Item9LabsCorp.com.
DCA case No. 1D18-4471
Filing date 8/16/19 #94296968 First district court of appeal.
It had been in appeal but that ended.
The Vertical licensing scheme here in Florida has come to an end today. The Court reversed the decision that a license must have you do all 3 grow, process, dispense. Look for brands entering the arena.
Could be something happening here?
Liberty Health Sciences Inc., a cannabis provider, has announced the launch of Zentient Labs a line of hemp-based CBD products made from a proprietary formula of CBD, nutraceuticals and vitamins that promote energy and focus for wellness seekers. Will be introducing Zentient to all of its dispensaries as its new house brand of products along with a Pretty Pistil, subject to the Florida Department of Health approval. Pretty Pistil will be replacing all of Liberty's Solei branded products. "Zentient will replace all of the Aphria and Liberty Health Science branded products moving forward,
Zentient Labs will include a line of products across numerous categories including propriety brands and partner brands. These categories will include an athletic line, a wellness line, beauty and premium pet products.Zentient will also introduce a wide arrange of products through its partnership with the Werc Shop and their one-of a-kind terpene blends, enabling Liberty to provide superior, standardized, and consistent medical cannabis products to the Florida market.
“We currently operate two facilities in Florida with a total cultivation capacity of over 41,000 square feet. (12/18)
“The company has increased its cultivation capacity to more than 120,000 square feet and will grow to approximately 225,000 square feet by early 2019.
The company has been selling flower for 4 months... Also Zentient has yet to replace liberty branded items, solei is still being sold and Werc Shop has itroduced.
I think they have been growing, I think that now that they no longer offer any discounts on flower that we will see 15%-20% more profit from flower. But that loss of discount caused a small ripple but even when every other company's discount guess who is cheaper? If they can get their flower right then no one will stop them without themselves lowering cost. Concentrate market is just opening but they must be getting ready for another brand or two or three. We need some shatter and crumble PERIOD!
Where does Papas herb cultivate from, Gainesville facility?
They do have new concentrates and there is a new strain of flower about to release. "Star Killer". Imagine if thc +25% would surely sell out fast. anything higher forget about it.. Thats all it would take.. Perfecting their cultivation in my opinion. Now Share price on the other hand, better communication from management?
Trader. I assure you that every week that liberty has blue dream which has been their first strain and sold until this day, but over and over and over. Quality, What do you think of it? When you grow only 2 strains of grass youre not pulling repeats bc of quality or selection. Ranging from 16-22.4%. Usually at 17.4-18.4. Then the A5 which most of US patients in florida would buy for 2 reasons 1) 28 bucks but the other was because it was ALWAYS higher thc than blue dream. But dont get excited boss its usually only 17-22.4. But 1 time thats right once! they grew it to 24.4. Now i know i do know more than you about the company day to day. I am sure of it. If they do not get their percentages up first off, and they need new strains. I know they have some tricks up their sleeve but the competition is growing 32% thc grass and thats what those who can afford want.
50mm Dollar debt hanging over their head, competitors like trulieve, growhealthy, Rise and MUV are really tearing in to the 2 strains liberty has to offer ALL the time same strain blue dream and A5. Both are low thc and both are played out. Thats why the drop. The competitors are excelling in quality
zuckerman pointed to one specific case: a college freshman from Florida whose lung collapsed. In an interview with The Daily Mail, the teen admitted to vaping about one JUUL pod every two days for a year.
https://www.cbsnews.com/news/teens-hospitalized-for-lung-damage-after-vaping-e-cigarettes-juul-health-risks/
Item 9 Labs Corp. Launches New Vape Pen and Cartridge Line Dubbed “Cocktails”
PHOENIX, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced the launch of its new product suite, “Cocktails,” a unique first to market disposable vape pen with cartridge and battery inspired by popular culture’s classic aperitifs.
The Item 9 Labs mixology team developed the craft-cannabis line utilizing organic fruit, botanically-derived terpenes, and 100 percent solvent-free distillate. The long-lasting disposable Cocktails vape pen is supplemented by a charging port for those patients who medicate less frequently. Cocktails comes with 300 mg. of premium distillate in four signature flavors including Blackberry Mojito, Piña Colada, Old Fashioned, and Strawberry Daiquiri.
With eye popping premium packaging and a minimalist sleek design, the Cocktails vape pen features a robust 280mAH breath-activated battery that lasts for approximately 300 inhales between recharges, offering cannabis patients a discreet, portable, and easy way to medicate.
The Company hosted an official brand kick-off event in Phoenix on July 26th. Nearly three hundred cannabis industry professionals attended the private event, where budtenders, buyers, and management from ten area dispensaries enjoyed a custom curated menu and themed cocktails celebrating the new product.
“The Cocktails brand embodies the company mantra ‘in good times.’ It’s a fresh approach to the growing wellness trend of alcohol-free bars coupled with the rise in vape product consumption,” stated Vice President of Marketing, Kyle Jennings.
According to Arcview Market Research, U.S. concentrate product sales are estimated to reach $8.4 billion by 2022, with vaping as the primary modality.
Headquartered in Phoenix, Item 9 Labs has received multiple accolades for its medical-grade flower and concentrates. Most recently, the Company’s Candyland and Tres Leches cannabis flower strains were named 1st Place Sativa and 2nd Place Hybrid respectively at Arizona’s 2019 Errl Cup Awards.
Item 9 Labs is bringing dynamic product suites and progressive new delivery platforms to the industry. Cocktails is available at select Arizona dispensaries, for more information visit Item9LabsCorp.com.
About Item 9 Labs Corp.:
Item 9 Labs Corp. (INLB) creates comfortable cannabis health solutions for the modern consumer. The Company is bringing best of industry practices to markets from coast to coast through cultivation and production, distinctive retail environments, licensing services, and diverse product suites catering to different medical cannabis demographics. Item 9 Labs Corp. is headquartered in Phoenix, Arizona, with medical cannabis operations in multiple U.S. markets.
Item 9 Labs Corp.’s asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. These assets provide services specific to different stakeholder groups. Dispensary Permits is the Company’s consulting firm specializing in strategic license application and compliance. Dispensary Templates, a subdivision of the firm, is a technology platform with an extensive digital library of licensing and business planning resources. Strive Life is a turnkey dispensary model for the retail sector, elevating the patient experience with consistent and superior service, high-end design, and precision-tested products. It is currently being implemented in Arizona and North Dakota.
In addition, Item 9 Labs Corp. is advancing the industry with its dynamic product suites. The Company has created complementary brands Item 9 Labs and Strive Wellness to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, as well as a pioneering intra-nasal device. The Company has received multiple accolades for its medical-grade flower and concentrates.
Item 9 Labs Corp. intends to manage cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets by the end of 2019. Current facilities include distribution and processing operation Strive Wellness of Nevada and dispensary Strive Life North Dakota.
For more information, visit Item 9 Labs Corp. at www.Item9labscorp.com.
The other state license is held by Southern University, which has selected Advanced Biomedics of Lafayette, based on a guaranteed $6 million in payments to operate the school's medical marijuana business. Ilera Hollistic Healthcare now holds license with crops planted and expected in late fall at earliest
100% GBLX market. Granted its a small market but thats why we get in now. Growth is inevitable. GBLX should assist as best they can to sign new patients. They must. Many MMJ doctors are prescribe in the same exact sense as pill mills. I know this from solid dd
Realistically could CV/PlusCBD have a partner already? Are there any type of business models we may follow or even speak in favor of that may clue to a partnership that is unable to be disclosed?
Dowling mentions competition. CW and greenroads etc. they hire people that say things like (complete nonsense) to trash the brand the company, the investor confidence is just gravy on top. Cannabis industry is cutthroat, with CVSI having the #1 selling CBD Oil. Business strategy has always been to attack the competitors brand and the company boards.
Nasdaq compliance for a CBD company that will add the product to national food and beverage brands I am sure needs special legal counsel.
MedMen offering 40.00 8ths in Florida regardless of strain or THC content has been generating much interest. The truth is that there is not enough open. I am completely sure that every mmj patient will buy from medmen when they are more easily accessible. 40 dollars for now is very competitive. Beaten only by 1 strain tier being 33.00 at trulieve and the rest 43.00 and 53.00. However trulieve does offer 29%thc for 33 when comes out that way. Liberty though... Now liberty has a chance to steal the flower market.. I just dont think they have the knowledge or the right set up to grow 30% flower.. But if they do achieve that or even 25-28 you bet that consumer will go to save the 19% (28.00) over the cheapest trulieve (33.00) offers. Now if trulieve and liberty only grow 17%-20% (which happens very commonly) then 40 is the next affordable price. Which leads me to believe if MedMen grows consistent high thc strains then the common flower user will trust (very often it is difficult to find a flower that will satisfy someone who only had the options of concentrates which brought their tolerance very high) that medmen will be able to meet their thc needs for flower..which often never happens among all dispensary in state. Any other listed operator in florida is not even relevant. Cant compete...yet
If Medmen has the ability to finely tune the thc/thcv/cbd/cbg/cbn then theyll be king.. anyone able to tune all the forks for the lowest cost will win.
Dont even want me to get in to the concentrates portion
Rampaging Bull. One wide eyed investor buying in to the perfected and tuned sales pitch, almost a sirens song to the novice investor. Then investor tells their friends and family about a company where there are "big things happening". And as they buy in and get strung along and as it ticks lower and lower until the next leg down. Then time passes and bill will catch another group and promise the world as the next leg down in share price.
GBS is at the best its ever been. The weight lifted from the company as we begin obvious 50% market of louisiana med use. Med use will overflow in to selling scripts. Louisiana will allow for more than enough milligrams ya understand? We may tick a few either direction you understand but ultimately were going up.. Wolf-man follows himself ya understand?
Here is what I have been gathering. Company has been acquiring gold rich land over the past few in anticipation of this inevitable explosion in gold price. With the renewed interest one would hope we have transparency.
a) On July 5, 2017, the Company issued 800,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $0.25 per unit for cash proceeds of $200,000. Each warrant entitles the holder to purchase one share of common stock at $0.25. The warrants are exercisable before July 5, 2020. The warrants may be called by the Company any time after July 5, 2018 with 30 days notice at a price of $0.05 per warrant .
b) On July 6, 2017, the Company issued 400,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $0.25 per unit for cash proceeds of $100,000. Each warrant entitles the holder to purchase one share of common stock at $0.25. The warrants are exercisable before July 6, 2020. The warrants may be called by the Company any time after July 6, 2018 with 30 days notice at a price of $0.05 per warrant.
c) On July 16, 2017, the Company issued 100,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $0.25 per unit for cash proceeds of $25,000. Each warrant entitles the holder to purchase one share of common stock at $0.25. The warrants are exercisable before July 16, 2020. The warrants may be called by the Company any time after July 16, 2018 with 30 days notice at a price of $0.05 per warrant.
d) On July 17, 2017, the Company issued 290,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $0.25 per unit for cash proceeds of $72,500. Each warrant entitles the holder to purchase one share of common stock at $0.25. The warrants are exercisable before July 17, 2020. The warrants may be called by the Company any time after July 17, 2018 with 30 days notice at a price of $0.05 per warrant.
e) On July 19, 2017, the Company issued 200,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $0.15 per unit to an arm’s length consultant in exchange for services of $30,000. Each warrant entitles the holder to purchase one share of common stock at $0.15. The warrants are exercisable before July 19, 2020. The warrants may be called by the Company any time after July 19, 2018 with 30 days notice at a price of $0.05 per warrant.
f) On July 20, 2017, the Company issued 100,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $0.25 per unit for cash proceeds of $25,000. Each warrant entitles the holder to purchase one share of common stock at $0.25. The warrants are exercisable before July 19, 2020. The warrants may be called by the issuer any time after July 20, 2018 with 30 days notice at a price of $0.05 per warrant.
g) On July 24, 2017, the Company issued 5,000 units of one share of common stock and one warrant to purchase one share of common stock at a price of $0.50 per unit for cash proceeds of $2,500. Each warrant entitles the holder to purchase one share of common stock at $2.00. The warrants are exercisable before July 24, 2018.
h) On August 8, 2017, the Company issued 10,000 units of one share of common stock and one warrant to purchase one share of common stock at a price of $1.25 per unit for cash proceeds of $12,500. Each warrant entitles the holder to purchase one share of common stock at $2.00. The warrants are exercisable before February 8, 2019.
i) On August 27, 2017, the Company issued 300,000 shares of common stock at $0.25 per share for cash proceeds of $75,000.
j) On December 7, 2017, the Company issued 20,000 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $1.25 per unit for cash proceeds of $25,000. Each warrant entitles the holder to purchase one share of common stock at $4.00. The warrants are exercisable before March 6, 2019.
k) On December 21, 2017, the Company issued 156,667 shares of common stock upon the exercise of 166,667 warrants exercised at $0.15 on a cashless basis. 10,000 shares of common stock were held back by the Company as consideration for the exercise.
l) On December 26, 2017, the Company issued 101,000 shares of common stock at $0.15 per share upon the exercise of 101,000 warrants.
m) On December 27, 2017, the Company issued 44,800 units consisting of one share of common stock and one warrant to purchase one share of common stock at a price of $1.25 per unit for cash proceeds of $56,000. Each warrant entitles the holder to purchase one share of common stock at $4.00. The warrants are exercisable before March 30, 2019.
n) On December 29, 2017, the Company issued 4,000 units at a price of $1.25 per unit for cash proceeds of $5,000. Each unit consists of one share of common stock, one warrant and one piggyback warrant. Each warrant entitles the holder to purchase one share of common stock at $2.00. Each piggyback warrant entitles the holder to purchase one share of common stock at $4.00. The warrant is exercisable before December 24, 2018 and the piggyback warrant is exercisable before December 24, 2019.
o) On December 29, 2017, the Company issued 16,000 units at $1.25 per unit for cash proceeds of $20,000. Each unit consists of one share of common stock, one warrant and one piggyback warrant. Each warrant entitles the holder to purchase one share of common stock at $2.00. Each piggyback warrant entitles the holder to purchase one share of common stock at $4.00. The warrant is exercisable before December 28, 2018 and the piggyback warrant is exercisable before December 28, 2019.
p) On October 17, 2017, the Company issued 66,667 shares of common stock at $0.15 per share upon the exercise of 66,667 warrants.
q) On October 31, 2017, the Company issued 315,500 shares of common stock at $0.15 per share upon the exercise of 315,500 warrants.
r) On November 7, 2017, the Company issued 15,500 shares of common stock at $0.25 per share for cash proceeds of $3,875.
s) On March 2, 2018, the Company issued 120,000 shares of common stock at $0.75 per share to an arm’s length consultant for marketing services provided, of which $42,557 is reflected as a prepaid expense at December 31, 2018 (June 30, 2018 - $84,706). The share value was based on the quoted value of the stock at the time of issue.
) On April 4, 2018, the Company issued 16,000 shares of common stock at $0.25 per share upon the exercise of 16,000 warrants.
u) On April 26, 2018, the Company issued 100,000 shares of common stock at $0.20 per share for cash proceeds of $20,000.
v) On April 26, 2018, the Company issued 166,667 shares of common stock at $0.20 per share for cash proceeds of $33,333.
w) On May 21, 2018, the Company issued 170,000 shares of common stock at $0.15 per share upon the exercise of 170,000 warrants.
x) On June 11, 2018, the Company issued 250,000 shares of common stock at $1.00 per share to an arm’s length consultant for referral services of which, $Nil is reflected as a prepaid expense as of December 31, 3018 (June 30, 3018 - $185,625). The share value was based on the quoted value of the stock at the time of issue.
y) On June 18, 2018, the Company issued 25,000 shares of common stock at $0.20 per share for cash proceeds of $5,000.
z) On June 20, 2018, the Company issued 20,000 shares of common stock at $0.80 per share to an arm’s length consultant for advisory services provided. The share value was based on the quoted value of the stock at the time of issue.
aa) On July 26, 2018, the Company issued 360,000 shares of common stock at $0.15 per share upon the exercise of 360,000 warrants. As of June 30, 2018, 193,333 of the warrants exercised had been reflected as shares to be issued.
bb) On July 26, 2018, the Company issued 15,000 shares of common stock at $0.80 per share in exchange for services of $12,000 to a consultant for advisory services provided.
cc) On July 26, 2018, the Company issued 206,667 shares of common stock at $0.15 per share. As of June 30, 2018, this had been reflected as shares to be issued.
dd) On July 31, 2018, the Company issued 150,000 shares of common stock to a consultant at $0.85 per share for advisory services of $127,500 pursuant to an agreement dated June 19, 2018. As of June 30, 2018, this had been reflected as shares to be issued.
ee) On August 3, 2018, the Company issued 333,333 shares of common stock at $0.15 per share upon the exercise of 333,333 warrants.
ff) On August 16, 2018, the Company issued 1,566,667 shares of common stock at $0.15 per share upon the exercise of 1,566,667 warrants. As of June 30, 2018, 1,266,667 of the warrants exercised had been reflected as shares to be issued.
gg) On August 27, 2018, the Company issued 100,000 shares of common stock at $0.15 per share for exercise of warrants.
hh) On September 5, 2018, the Company issued 66,667 shares of common stock at $0.15 per share upon the exercise of 66,667 warrants.
ii) On September 6, 2018, the Company issued 300,000 shares of common stock at $0.25 per share upon the exercise of 300,000 warrants.
jj) On September 6, 2018, the Company issued 200,000 shares of common stock at $0.15 per share upon the exercise of 200,000 warrants.
(kk) On October 4, 2018, the Company issued 15,000 shares of common stock at $0.70 per share to an arm’s length consultant for advisory services provided. The share value was based on the quoted value of the stock at the time of issue.
(ll) On October 12, 2018, the Company issued 100,000 shares of common stock at $0.62 per share to an arm’s length consultant for advisory services provided. The share value was based on the quoted value of the stock at the time of issue.
(mm) On October 24, 2018, the Company issued 263,525 shares of common stock at $0.15 per share upon the exercise of 263,525 warrants.
(nn) On December 18, 2018, the Company issued 20,000 shares of common stock at $0.80 per share to to an arm’s length consultant for advisory services provided. The share value was based on the quoted value of the stock at the time of issue.
(oo) On March 1, 2019, the Company issued 100,000 shares of common stock at $0.60 per share to an Officer of the Company as was provided for according to his employment agreement signed in November 2018. The share value was based on the quoted value of the stock at the time of signing the agreement.
Event Horizon with the company..Finally the second phase is implemented. We are in every shop in Louisiana. The state and(GBLX) have very deep roots together. This will begin to bear good fruit
Dakota Territory Resource Corp Enters Key Geological and Environmental Consulting Relationship with TAD Services LLCPress Release | 08/07/2019
Reno, Nevada, Aug. 07, 2019 (GLOBE NEWSWIRE) --
Dakota Territory Resource Corp (OTCQB: DTRC) ("Dakota Territory" or the "Company") is pleased to announce today that the Company has entered into a key consulting agreement with TAD Services LLC., a consulting company founded by Todd Duex of Spearfish, South Dakota. Mr. Duex has more than 40 years experience in the mining industry, including 34 years in the Black Hills of South Dakota where Mr. Duex has been responsible for managing all aspects of gold projects – from grass roots exploration through mine development, production and into final mine closure.
TAD Services will assist Dakota Territory in the execution of its strategic development objectives in the northern Black Hills area. Mr. Duex has personally developed and implemented exploration programs in the district based initially on geophysics and geochemistry that were successful in discovering Tertiary-aged gold deposits. Todd’s experience in this area provides a critical addition to the extensive Precambrian expertise of Dakota Territory’s technical team as the Company continues to build on its strategically dominant land position in the Homestake District.
For the past 20 years, Mr. Duex has been managing Barrick Gold’s mine closure projects in the Black Hills. In this capacity, Todd has gained extensive environmental management experience and has developed an excellent working relationship with the community, as well as State and County regulatory authorities. With Todd’s valuable environmental background, Dakota Territory will immediately begin the process of permitting the Blind Gold and City Creek Properties for drilling. “We believe that securing drill permits is fundamental to building real value in our projects as we begin to attract interest from potential joint venture partners that are prepared to drill,” said Jerry Aberle, Dakota Territory’s President and CEO. “We intend to be prepared to drill as this gold rally breathes new life into exploration projects located in the safe low cost gold districts of the American West. We are in the right place at good time for gold projects and we believe that Todd is ideally suited to help us execute our short and long term exploration plans”.
Vie.gg
I am starting to load up again. I believe GREAT efforts in this quarter are being made to show compliance for uplist..I'll keep loading until the first ever World Esports Championsip.. It will be bigger than the superbowl. As far as timing goes, I watch my 6yr old niece enjoy watching others play videogames on the youtube.
Mark my words She is the future and so is gaming and wagering on that will grow greatly.
Dakota Territory Resource Corp Substantially Increases Land Position
Through this most recent staking, the City Creek project area has been expanded from approximately 449 acres to 1,167 acres.
Dakota Territory controls just over 4,000 acres of brownfields mineral property in one of America’s richest gold districts. The Company intends to continue to strategically expand its dominant land package in the district as industry interest grows for exploration property in safe, low cost jurisdictions in the United States with a history of large-scale gold production.
The Homestake Paleoplacer Channel
The Channel Extension (CE) drill program cut a total of 5,726 meters from 27 drill holes, including CE 12A and CE 16, both of which were collared and drilled on Mineral Survey 1706. Drill hole CE 16 intersected 3 meters of flat lying quartz-pebble conglomerate of the basal Deadwood Formation assaying 5.85 grams per ton gold at a depth 164 meters below the surface. Additionally, drill hole CE12A intersected 2 meters of Deadwood Formation assaying 8.46 grams per ton gold at a depth of 192 meters below the surface.
Who doesn't want to be a Gold prospector?
Very happy to hear about what Co-founders of the hemp authority, producer of the #1 selling cbd balm, the friend of the American farmer, the recently announced global expansion interested, quite possibly PlusTHC tm has to say about the rapidly growing company
Trend reversal?